Fauci on COVID Drugs, Vaccines and Getting Back to Normal
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens
The U.S.’s top infectious disease specialist describes a new Biden administration program to develop and test antivirals—and what he’s most worried about as the nation reopens
Developing pills that block the novel coronavirus has been challenging. A new Biden administration program aims to boost the effort
Genomic sequencing efforts are limited in developing countries, but scientists are mobilizing to help
More than a year into the SARS-CoV-2 pandemic, some scientists say the possibility of a lab leak never got a fair look.
Vaccine makers are designing follow-up shots, based on new mutations, to keep the disease at bay
Companies are scrambling to obtain supplies for hundreds of millions of doses of a type of vaccine that has never been made at this scale before
Copyright © 2026 | WordPress Theme by MH Themes